Product NDC: | 0054-3090 |
Proprietary Name: | Butorphanol Tartrate |
Non Proprietary Name: | Butorphanol Tartrate |
Active Ingredient(s): | 10 mg/mL & nbsp; Butorphanol Tartrate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-3090 |
Labeler Name: | Roxane Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075824 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020312 |
Package NDC: | 0054-3090-36 |
Package Description: | 1 BOTTLE, SPRAY in 1 CONTAINER (0054-3090-36) > 15 mL in 1 BOTTLE, SPRAY |
NDC Code | 0054-3090-36 |
Proprietary Name | Butorphanol Tartrate |
Package Description | 1 BOTTLE, SPRAY in 1 CONTAINER (0054-3090-36) > 15 mL in 1 BOTTLE, SPRAY |
Product NDC | 0054-3090 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Butorphanol Tartrate |
Dosage Form Name | SPRAY, METERED |
Route Name | NASAL |
Start Marketing Date | 20020312 |
Marketing Category Name | ANDA |
Labeler Name | Roxane Laboratories, Inc |
Substance Name | BUTORPHANOL TARTRATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |